OTCMKTS:KCDMY

Kimberly-Clark de México, S. A. B. de C. V. Competitors

$8.60
-0.08 (-0.92 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.50
Now: $8.60
$8.87
50-Day Range
$7.96
MA: $8.34
$8.72
52-Week Range
$6.00
Now: $8.60
$9.51
Volume17,938 shs
Average Volume55,107 shs
Market Capitalization$5.31 billion
P/E Ratio18.30
Dividend Yield4.26%
Beta0.46

Competitors

Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) Vs. SOMLY, SBMFF, ESALY, NRILY, FRRVY, and ERFSF

Should you be buying KCDMY stock or one of its competitors? Companies in the industry of "private households" are considered alternatives and competitors to Kimberly-Clark de México, S. A. B. de C. V., including Secom (SOMLY), Sino Biopharmaceutical (SBMFF), Eisai (ESALY), Nomura Research Institute (NRILY), Ferrovial (FRRVY), and Eurofins Scientific (ERFSF).

Secom (OTCMKTS:SOMLY) and Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation.

Dividends

Secom pays an annual dividend of $0.28 per share and has a dividend yield of 1.3%. Kimberly-Clark de México, S. A. B. de C. V. pays an annual dividend of $0.37 per share and has a dividend yield of 4.3%. Secom pays out 28.6% of its earnings in the form of a dividend.

Insider & Institutional Ownership

0.2% of Secom shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Secom and Kimberly-Clark de México, S. A. B. de C. V.'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Secom$9.75 billion2.05$799.41 million$0.9821.83
Kimberly-Clark de México, S. A. B. de C. V.$2.26 billion2.35$268.12 millionN/AN/A

Secom has higher revenue and earnings than Kimberly-Clark de México, S. A. B. de C. V..

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Secom and Kimberly-Clark de México, S. A. B. de C. V., as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Secom0000N/A
Kimberly-Clark de México, S. A. B. de C. V.00203.00

Profitability

This table compares Secom and Kimberly-Clark de México, S. A. B. de C. V.'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Secom7.44%6.92%4.41%
Kimberly-Clark de México, S. A. B. de C. V.12.92%154.39%12.33%

Risk & Volatility

Secom has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, Kimberly-Clark de México, S. A. B. de C. V. has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500.

Summary

Kimberly-Clark de México, S. A. B. de C. V. beats Secom on 8 of the 12 factors compared between the two stocks.

Sino Biopharmaceutical (OTCMKTS:SBMFF) and Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability.

Earnings and Valuation

This table compares Sino Biopharmaceutical and Kimberly-Clark de México, S. A. B. de C. V.'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sino Biopharmaceutical$3.51 billion5.68$391.67 millionN/AN/A
Kimberly-Clark de México, S. A. B. de C. V.$2.26 billion2.35$268.12 millionN/AN/A

Sino Biopharmaceutical has higher revenue and earnings than Kimberly-Clark de México, S. A. B. de C. V..

Profitability

This table compares Sino Biopharmaceutical and Kimberly-Clark de México, S. A. B. de C. V.'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sino BiopharmaceuticalN/AN/AN/A
Kimberly-Clark de México, S. A. B. de C. V.12.92%154.39%12.33%

Volatility & Risk

Sino Biopharmaceutical has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Kimberly-Clark de México, S. A. B. de C. V. has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Sino Biopharmaceutical and Kimberly-Clark de México, S. A. B. de C. V., as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sino Biopharmaceutical02102.33
Kimberly-Clark de México, S. A. B. de C. V.00203.00

Summary

Kimberly-Clark de México, S. A. B. de C. V. beats Sino Biopharmaceutical on 5 of the 9 factors compared between the two stocks.

Eisai (OTCMKTS:ESALY) and Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations and institutional ownership.

Dividends

Eisai pays an annual dividend of $1.30 per share and has a dividend yield of 1.9%. Kimberly-Clark de México, S. A. B. de C. V. pays an annual dividend of $0.37 per share and has a dividend yield of 4.3%. Eisai pays out 33.2% of its earnings in the form of a dividend.

Institutional and Insider Ownership

0.1% of Eisai shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Eisai and Kimberly-Clark de México, S. A. B. de C. V., as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eisai00103.00
Kimberly-Clark de México, S. A. B. de C. V.00203.00

Profitability

This table compares Eisai and Kimberly-Clark de México, S. A. B. de C. V.'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eisai16.86%17.44%11.48%
Kimberly-Clark de México, S. A. B. de C. V.12.92%154.39%12.33%

Valuation and Earnings

This table compares Eisai and Kimberly-Clark de México, S. A. B. de C. V.'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eisai$6.40 billion3.11$1.12 billion$3.9117.17
Kimberly-Clark de México, S. A. B. de C. V.$2.26 billion2.35$268.12 millionN/AN/A

Eisai has higher revenue and earnings than Kimberly-Clark de México, S. A. B. de C. V..

Risk and Volatility

Eisai has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Kimberly-Clark de México, S. A. B. de C. V. has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.

Summary

Kimberly-Clark de México, S. A. B. de C. V. beats Eisai on 7 of the 12 factors compared between the two stocks.

Nomura Research Institute (OTCMKTS:NRILY) and Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, earnings, risk and analyst recommendations.

Valuation and Earnings

This table compares Nomura Research Institute and Kimberly-Clark de México, S. A. B. de C. V.'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nomura Research Institute$4.87 billion4.06$636.67 million$1.0030.81
Kimberly-Clark de México, S. A. B. de C. V.$2.26 billion2.35$268.12 millionN/AN/A

Nomura Research Institute has higher revenue and earnings than Kimberly-Clark de México, S. A. B. de C. V..

Dividends

Nomura Research Institute pays an annual dividend of $0.23 per share and has a dividend yield of 0.7%. Kimberly-Clark de México, S. A. B. de C. V. pays an annual dividend of $0.37 per share and has a dividend yield of 4.3%. Nomura Research Institute pays out 23.0% of its earnings in the form of a dividend.

Risk & Volatility

Nomura Research Institute has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Kimberly-Clark de México, S. A. B. de C. V. has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Nomura Research Institute and Kimberly-Clark de México, S. A. B. de C. V., as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nomura Research Institute0000N/A
Kimberly-Clark de México, S. A. B. de C. V.00203.00

Profitability

This table compares Nomura Research Institute and Kimberly-Clark de México, S. A. B. de C. V.'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nomura Research Institute10.15%18.86%10.28%
Kimberly-Clark de México, S. A. B. de C. V.12.92%154.39%12.33%

Summary

Kimberly-Clark de México, S. A. B. de C. V. beats Nomura Research Institute on 6 of the 10 factors compared between the two stocks.

Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) and Ferrovial (OTCMKTS:FRRVY) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Risk & Volatility

Kimberly-Clark de México, S. A. B. de C. V. has a beta of 0.46, suggesting that its stock price is 54% less volatile than the S&P 500. Comparatively, Ferrovial has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.

Earnings and Valuation

This table compares Kimberly-Clark de México, S. A. B. de C. V. and Ferrovial's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kimberly-Clark de México, S. A. B. de C. V.$2.26 billion2.35$268.12 millionN/AN/A
Ferrovial$6.78 billion2.87$-529,090,000.00N/AN/A

Kimberly-Clark de México, S. A. B. de C. V. has higher earnings, but lower revenue than Ferrovial.

Profitability

This table compares Kimberly-Clark de México, S. A. B. de C. V. and Ferrovial's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Kimberly-Clark de México, S. A. B. de C. V.12.92%154.39%12.33%
FerrovialN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Kimberly-Clark de México, S. A. B. de C. V. and Ferrovial, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Kimberly-Clark de México, S. A. B. de C. V.00203.00
Ferrovial01602.86

Insider and Institutional Ownership

0.1% of Ferrovial shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Eurofins Scientific (OTCMKTS:ERFSF) and Kimberly-Clark de México, S. A. B. de C. V. (OTCMKTS:KCDMY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Profitability

This table compares Eurofins Scientific and Kimberly-Clark de México, S. A. B. de C. V.'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eurofins ScientificN/AN/AN/A
Kimberly-Clark de México, S. A. B. de C. V.12.92%154.39%12.33%

Analyst Recommendations

This is a summary of recent recommendations for Eurofins Scientific and Kimberly-Clark de México, S. A. B. de C. V., as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eurofins Scientific20402.33
Kimberly-Clark de México, S. A. B. de C. V.00203.00

Risk & Volatility

Eurofins Scientific has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Kimberly-Clark de México, S. A. B. de C. V. has a beta of 0.46, suggesting that its stock price is 54% less volatile than the S&P 500.

Earnings and Valuation

This table compares Eurofins Scientific and Kimberly-Clark de México, S. A. B. de C. V.'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eurofins Scientific$5.19 billion3.50$218.74 million$2.2645.13
Kimberly-Clark de México, S. A. B. de C. V.$2.26 billion2.35$268.12 millionN/AN/A

Kimberly-Clark de México, S. A. B. de C. V. has lower revenue, but higher earnings than Eurofins Scientific.


Kimberly-Clark de México, S. A. B. de C. V. Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Secom logo
SOMLY
Secom
1.3$21.39-1.0%$19.96 billion$9.75 billion26.09
Sino Biopharmaceutical logo
SBMFF
Sino Biopharmaceutical
0.8$1.06-0.0%$19.92 billion$3.51 billion0.00
Eisai logo
ESALY
Eisai
1.3$67.14-1.2%$19.91 billion$6.40 billion17.35Analyst Downgrade
Nomura Research Institute logo
NRILY
Nomura Research Institute
1.1$30.81-0.0%$19.74 billion$4.87 billion36.25
Ferrovial logo
FRRVY
Ferrovial
0.5$26.51-0.5%$19.43 billion$6.78 billion0.00
Eurofins Scientific logo
ERFSF
Eurofins Scientific
0.9$102.00-0.6%$18.16 billion$5.19 billion45.13News Coverage
OMRON logo
OMRNY
OMRON
1.0$84.41-0.4%$17.41 billion$6.24 billion0.00
Deutsche Wohnen logo
DWHHF
Deutsche Wohnen
0.9$48.28-0.0%$17.37 billion$937.88 million14.12
Rakuten logo
RKUNY
Rakuten
0.6$12.06-0.2%$17.33 billion$11.60 billion-19.77News Coverage
Chow Tai Fook Jewellery Group logo
CJEWY
Chow Tai Fook Jewellery Group
1.2$16.89-0.1%$16.89 billion$7.26 billion45.65
OMV Aktiengesellschaft logo
OMVJF
OMV Aktiengesellschaft
1.0$51.22-0.0%$16.72 billion$26.28 billion-51.74
NN Group logo
NNGRY
NN Group
1.1$25.23-0.2%$16.67 billion$22.92 billion7.84
COSCO SHIPPING logo
CICOY
COSCO SHIPPING
0.8$8.15-3.7%$16.65 billion$21.78 billion101.88High Trading Volume
Gap Up
Atlantia logo
ATASY
Atlantia
0.6$9.72-0.2%$16.05 billion$14.13 billion108.00News Coverage
Surgutneftegas Public Joint Stock logo
SGTZY
Surgutneftegas Public Joint Stock
0.1$4.40-0.9%$15.72 billion$28.13 billion0.00News Coverage
bioMérieux logo
BMXMF
bioMérieux
0.5$132.00-0.0%$15.62 billion$3.00 billion51.16
Terna - Rete Elettrica Nazionale Società per Azioni logo
TEZNY
Terna - Rete Elettrica Nazionale Società per Azioni
0.6$21.90-1.6%$14.67 billionN/A0.00
Carrefour logo
CRRFY
Carrefour
1.1$3.58-2.0%$14.64 billion$81.09 billion13.77
Schroders logo
SHNWF
Schroders
0.9$51.20-7.6%$14.46 billion$3.24 billion20.24
Persimmon logo
PSMMY
Persimmon
1.3$90.19-2.6%$14.39 billion$4.66 billion13.13
Sompo logo
SMPNY
Sompo
1.7$19.02-0.0%$14.20 billion$34.60 billion10.81
Randstad logo
RANJY
Randstad
1.3$37.98-2.1%$13.97 billion$26.52 billion48.69
MonotaRO logo
MONOY
MonotaRO
1.1$55.10-5.1%$13.81 billion$1.21 billion122.45Analyst Upgrade
News Coverage
Gap Down
Kumba Iron Ore logo
KIROY
Kumba Iron Ore
0.8$14.15-0.0%$13.67 billion$4.45 billion0.00News Coverage
Yara International ASA logo
YARIY
Yara International ASA
1.5$25.24-1.6%$13.54 billion$12.94 billion20.86Analyst Downgrade
Brenntag logo
BNTGY
Brenntag
1.2$17.49-0.1%$13.51 billion$14.36 billion25.72
Halma logo
HLMAF
Halma
0.8$35.40-1.8%$13.44 billion$1.70 billion48.49Analyst Revision
News Coverage
Gap Down
Edenred logo
EDNMY
Edenred
0.4$27.10-0.9%$13.36 billion$1.82 billion0.00
Nitto Denko logo
NDEKY
Nitto Denko
1.1$44.61-1.3%$13.36 billion$6.82 billion32.09Analyst Downgrade
SEGRO logo
SEGXF
SEGRO
0.5$13.10-0.0%$13.14 billion$552.27 million0.00Analyst Upgrade
Covestro logo
COVTY
Covestro
1.1$33.45-0.5%$12.93 billion$13.90 billion56.70
Mondi logo
MONDY
Mondi
1.6$52.85-0.5%$12.83 billion$8.14 billion13.69Analyst Upgrade
Bureau Veritas logo
BVRDF
Bureau Veritas
0.9$28.66-0.0%$12.80 billion$5.71 billion25.14Analyst Report
Davide Campari-Milano logo
DVDCF
Davide Campari-Milano
1.2$11.04-0.0%$12.71 billion$2.06 billion42.46Analyst Report
News Coverage
HRELY
Haier Electronics Group
0.7$44.88-0.0%$12.64 billion$10.98 billion21.27
Croda International logo
COIHY
Croda International
1.0$45.21-0.5%$12.62 billion$1.76 billion38.31Gap Down
Renault logo
RNLSY
Renault
0.7$8.52-0.9%$12.60 billion$62.21 billion-71.00News Coverage
Disco logo
DSCSY
Disco
1.3$69.79-0.0%$12.58 billion$1.30 billion43.62Analyst Revision
News Coverage
Smurfit Kappa Group logo
SMFKY
Smurfit Kappa Group
1.5$48.33-0.1%$12.52 billion$10.13 billion15.85
Spirax-Sarco Engineering logo
SPXSF
Spirax-Sarco Engineering
0.7$165.20-1.2%$12.17 billion$1.59 billion48.88High Trading Volume
News Coverage
Air China logo
AIRYY
Air China
1.0$16.74-0.0%$12.16 billion$33.09 billion-7.64
GN Store Nord A/S logo
GNNDY
GN Store Nord A/S
1.1$254.00-2.0%$12.05 billion$1.89 billion56.82
ageas SA/NV logo
AGESY
ageas SA/NV
1.3$61.35-0.8%$11.94 billion$16.91 billion9.48News Coverage
Brambles logo
BXBLY
Brambles
1.3$16.24-0.3%$11.90 billion$4.73 billion24.98
CLLDY
CapitaLand
1.0$5.68-0.5%$11.85 billion$4.57 billion9.01Gap Up
COIHD
Croda International
1.2$45.21-0.5%$11.62 billion$1.85 billion35.05Gap Down
ZTE logo
ZTCOY
ZTE
1.4$5.01-2.0%$11.56 billion$13.00 billion14.74Analyst Upgrade
MTN Group logo
MTNOY
MTN Group
0.5$6.12-0.3%$11.47 billion$10.49 billion0.00High Trading Volume
Burberry Group logo
BURBY
Burberry Group
0.8$28.26-2.5%$11.44 billion$3.37 billion27.98
Davide Campari-Milano logo
DVDCY
Davide Campari-Milano
1.3$9.85-5.2%$11.34 billion$2.06 billion37.88News Coverage
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.